LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19, 2024.
This exclusive Live Course on the latest updates in lung cancer treatment, specifically focusing on immunotherapy, offers a deep dive into the transformative impact of immunotherapy on lung cancer care in Latin America (LATAM). In Series II of the course, leading thoracic oncology experts from the region will lead discussions on pivotal aspects of immunotherapy in lung cancer treatment.
Key topics will include the integration of biomarkers for immunotherapy, which play a critical role in selecting the right patients and optimizing treatment efficacy. Experts will also explore best management strategies for advanced lung cancer, addressing the evolving landscape of treatment options, and discuss specific challenges faced in clinical practice, such as the management of pneumonitis, a common side effect associated with immunotherapy.
The Link for Registration.
See the Speakers and Series II LATAM Team Below:
